Conference report of the 9th meeting of the International Scientific Working Group of Tick Borne Encephalitis (ISW TBE). Tick Borne Encephalitis: From epidemiology to current vaccination recommendations

Vaccine

Volumn 25, Issue 50, 2007, Pages 8350-8351

  Kunze, Ursula ^a  

^a Medical University of Vienna   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TICK BORNE ENCEPHALITIS VACCINE;

ANTIBODY BLOOD LEVEL; ARBOVIRUS; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; EUROPE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MORBIDITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; TICK BORNE ENCEPHALITIS; VACCINATION; WORLD HEALTH ORGANIZATION;

ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; EUROPE; HUMANS; TRAVEL; VACCINATION; VIRAL VACCINES;

EID: 36248972586     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.059     Document Type: Conference Paper

References (14)

1. WHO. World Health Organization. The Vector-borne Human Infections of Europe (2004), WHO p. 37-49
2. Süss J. Zunehmende Verbreitung der Frühsommer-Meningoenzephalitis in Europa. Dtsch Med Wschr 130 (2005) 1397-1400
3. Kunze U and the ISW TBE. Tick-borne encephalitis-a European health challenge. Conference report of the 8th meeting of the International Scientific Working Group on Tick-borne Encephalitis (ISW TBE). Wien Med Wochenschr 2006;156:376-78.
4. Rendi-Wagner P. Risk and prevention of tick-borne encephalitis in travelers. J Travel Med 11 (2004) 307-312
5. Fessl GFK. TBE vaccination in Austria: Results of a representative survey of the Austrian population. Fessl Gfk Institute 2006, Vienna, Austria.
6. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 (2003) 50-55
7. Randolph S. Predicting the risk of tick-borne diseases. Int J Med Microbiol 291 (2002) 6-10
8. Randolph S. Evidence that climate change has caused "emergence" of Tick-borne disease in Europe?. Int J Med Microbiol 293 (2004) 5-15
9. Haglund M. Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE). Int J Med Microbiol 291 (2002) 50-54
10. Skarpaas T., Ljostad U., and Sundoy A. The first human cases of tick-borne encephalitis in Norway. Emerg Infect Dis 12 (2004) 2241-2243
11. De Valliere S., Cometta A., Zimmermann H., Vaudaux B., and Meylan P. Evidence of new foci of tick-borne encephalitis in the French speaking part of Switzerland. Rev Med Suisse 80 (2006) 2191-2194
12. Günther G., and Haglund M. Tick-Borne Encephalopathies: Epidemiology, diagnosis, treatment and prevention. CNS Drugs 12 (2005) 1009-1032
13. Loew-Baselli A., Poellerbauer E.M., Frtisch S., Koska M., Vartian N., Himly C., et al. Immunogenicity and safety of FSME-IMMUN 0.5ml using a rapid immunization schedule. Int J Med Microbiol 296 (2006) 213-214
14. Beran J., Douda P., Gniel D., and Zent O. Long-term immunity after vaccination against tick-borne endephalitis with Encepur using the rapid vaccination schedule. Int J Med Microbiol 293 (2004) 130-133